The largest study to date on BioCell Collagen found that the ingredient significantly reduced common signs of aging such as facial wrinkles and crow's feet.
A study recently published in Alternative Therapies in Health and Medicine1 found that BioCell Collagen visibly reduced common signs of aging within 12 weeks of daily use. In the randomized, double-blind, placebo-controlled clinical trial, 128 females between the ages of 39 and 59 were assigned to either take placebo, or 1 g per day of BioCell Collagen, consisting of a matrix of hydrolyzed collagen type II, chondroitin sulfate, and hyaluronic acid derived from chicken sternal cartilage.
Results showed that compared to placebo, those taking the collagen supplement saw a significant reduction in facial lines and wrinkles, crow’s feet lines and wrinkles, increased skin elasticity and cutaneous collagen content, as well as decreased skin dryness and erythema. “This landmark research is especially encouraging for women who are seeking safe and effective options for meeting their skin health and appearance goals, including those who are considering or already using cosmetic procedures to address skin aging,” said Alexander Schauss, PhD, co-author of the study, in a press release.
"We are very excited about the publication of our largest study to date, which further supports the efficacy and safety of our flagship dietary ingredient BioCell Collagen as a key component to a healthy aging routine," said Suhail Ishaq, president of BioCell Technology, in a press release. “Those who are considering procedures to address signs of aging in skin should know their options. This substantive study adds to a body of evidence and years of study that show how the dietary supplement ingredient BioCell Collagen can be used as part of a skin health routine for people who are looking for more subtle and natural improvements in their appearance.”
1. Schwartz SR et al. “Novel hydrolyzed chicken sternal cartilage extract improves facial epidermis and connective tissue in healthy adult females: a randomized, double-blind, placebo-controlled trial.” Alternative Therapies in Health and Medicine, Published online ahead of print on June 13, 2019